indication
For the treatment of pulmonary artery anomalies
pharmacology
Tolazoline is a pulmonary vasodilator indicated used to decrease pulmonary vascular resistance (PVR) in persistent pulmonary hypertension of the newborn (PPHN).
mechanism of action
Vasodilation by means of a direct effect on peripheral vascular smooth muscle and indirect effects produced, in part, by release of endogenous histamine; tolazoline has moderate alpha-adrenergic blocking activity and has histamine agonist activity. Tolazoline usually reduces pulmonary arterial pressure and vascular resistance.
drug interactions
Cimetidine: Anticipated loss of efficacy of tolazoline
Ranitidine: Anticipated loss of efficacy of tolazoline
Treprostinil: Additive hypotensive effect. Monitor antihypertensive therapy during concomitant use.